deferiprone
Term · Oncology and biomedicine · MLC-T-ONC-012946
An orally bioavailable bidentate ligand with iron chelating activity. Deferiprone binds to iron in a 3:1 (ligand:iron) molar ratio. By binding to iron, deferiprone is able to remove excess iron from the body.
| Identifier | MLC-T-ONC-012946 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012946",
"term": "deferiprone",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable bidentate ligand with iron chelating activity. Deferiprone binds to iron in a 3:1 (ligand:iron) molar ratio. By binding to iron, deferiprone is able to remove excess iron from the body.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/deferiprone/"
}
Record 5,767 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.